Philadelphia, PA – December 28, 2010 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that, in connection with its previously announced...

Philadelphia, PA – December 17, 2010 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced the closing of its previously announced underwritten...

Philadelphia, PA – December 14, 2010 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has priced an underwritten public offering...

Philadelphia, PA – December 13, 2010 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it intends, subject to market and other...

Philadelphia, PA – November 11, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2011 first quarter ended September 30, 2010. For the first...

Philadelphia, PA – November 4, 2010 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2011...

Philadelphia, PA – October 18, 2010 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has commenced shipping Fluphenazine HCl...

Philadelphia, PA – September 29, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today said that the U.S. Food and Drug Administration (FDA) recently completed inspections of the...

Philadelphia, PA – September 14, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) announced that today it purchased 1,270 shares of its common stock in the open market under the...

Philadelphia, PA - September 13, 2010 - Lannett Company, Inc. (NYSE AMEX: LCD today reported financial results for the fiscal 2010 fourth quarter and full year ended June 30, 2010. For the 2010...

Philadelphia, PA – September 7, 2010 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010...

Philadelphia, PA – August 6, 2010 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced today that it has received approval from the U.S. Food and...

Philadelphia, PA – August 5, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Arthur Bedrosian, president and chief executive officer, will present a company overview...

Philadelphia, PA – July 20, 2010 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...